Amy E. Begley, MA
- 5Articles
- 18.2KReads1
- 1997–2014Active
- 25Collaborators
- 163Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Amy E. Begley, MA, has contributed to research on major depressive disorder, focusing on treatment-resistant depression, electroconvulsive therapy, and late-life depression. Her work includes studies on the safety and clinical effects of pharmacological treatments such as low-dose buprenorphine and combinations of nortriptyline with other agents. She has also examined risk factors for falls during depression treatment and the impact of adjunctive medications like lorazepam on antidepressant response. Her publications span neurology and suicide risk within depressive disorders.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
